Drag a card by its title · ⚙ to size, swap or remove

The company

Harmony Biosciences Holdings, Inc.

HRMY · Nasdaq

Health CarePharmaceuticalsLeading

HRMY stood above a rising 150-day average in 28 of the last 52 weekly readings, including each of the last 9 weeks. It is 8.9% above that average now. Pharmaceuticals: 31% of its 74 stocks in an uptrend (−7 points in four weeks); Health Care: 25% (−11 points in four weeks).

SEC filings

Statistics

Rotation: Leading
Weeks in an uptrend: 9 in a row
Industry in uptrend: 31% -7 in 4 wk
Insider buys, 12 months: $0
Insider sales, 12 months: $10.0M
Officials’ trades on record: 3
Institutions holding: 300 (+16)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 28 of 52 weeks.

17 Apr – 16 Oct

Pharmaceuticals: A minority of its stocks are in an uptrend and the share has been slipping. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026

Open-market buys above the line and sales below, in dollars.

Congress and officials

3 disclosed lines: House 0, Senate 0, executive 3; 1 people.

Who	Did	Amount	Traded
Donald J. Trump Executive branch: Office of Government EthicsWhite House Office	bought	$15k–$50k	30 Mar 2026filed 14 May 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Office	sold	$15k–$50k	26 Feb 2026filed 14 May 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Office	bought	$15k–$50k	26 Jan 2026filed 14 May 2026

Insiders

Buy orders, 12 months0

Sale orders, 12 months10

Buyers · sellers0 · 3

Who	Did	Shares	Traded
Kumar BudurCHIEF MEDICAL OFFICER	sold	35,852at $43.05	18 Sep 2026filed 18 Sep 2026
Kumar BudurCHIEF MEDICAL OFFICER	sold	800at $43.00	17 Sep 2026filed 18 Sep 2026
Kumar BudurCHIEF MEDICAL OFFICER	sold	1,800at $43.01	16 Sep 2026filed 18 Sep 2026
Kumar BudurCHIEF MEDICAL OFFICER	sold	4,500at $42.25	8 Sep 2026filed 9 Sep 2026
Kumar BudurCHIEF MEDICAL OFFICER	sold	1,000at $42.79	8 Sep 2026filed 9 Sep 2026
Kumar BudurCHIEF MEDICAL OFFICER	sold	22,954at $43.10	8 Sep 2026filed 9 Sep 2026
Kumar BudurCHIEF MEDICAL OFFICER	sold	5,500at $41.98	4 Sep 2026filed 9 Sep 2026
Sandip KapadiaCHIEF FINANCIAL OFFICER	sold	3,746at $37.15	26 Jan 2026filed 28 Jan 2026
Sandip KapadiaCHIEF FINANCIAL OFFICER	sold	20,961at $35.92	15 Jan 2026filed 20 Jan 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders300+16 on the quarter

New · exited52 · 35

Reported value$1.8B

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

Manager	Shares	Change
BlackRock, Inc.added · filed 7 Aug 2026	7,101,965$258.6M	+31,930+0.5%
FMR LLCadded · filed 13 Aug 2026	3,574,115$130.1M	+416,476+13.2%
VANGUARD PORTFOLIO MANAGEMENT LLCadded · filed 13 Aug 2026	2,880,489$104.9M	+166,136+6.1%
AMERICAN CENTURY COMPANIES INCadded · filed 12 Aug 2026	2,539,512$92.5M	+434,333+20.6%
DIMENSIONAL FUND ADVISORS LPadded · filed 11 Aug 2026	2,393,588$87.1M	+317,078+15.3%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026	2,105,053$76.6M	+2,738+0.1%
STATE STREET CORPadded · filed 7 Aug 2026	1,859,322$67.7M	+74,960+4.2%
ARMISTICE CAPITAL, LLCreduced · filed 14 Aug 2026	1,564,000$56.9M	-60,000−3.7%
GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 2026	1,442,649$52.5M	+119,929+9.1%
ARROWSTREET CAPITAL, LIMITED PARTNERSHIPreduced · filed 13 Aug 2026	1,312,550$47.8M	-69,563−5.0%